Shorter radiation may mean less scarring for breast cancer patients

NCT ID NCT02755896

Ongoing Symptom relief Sponsor: Weill Medical College of Cornell University Source: ClinicalTrials.gov ↗

First seen Jan 08, 2026 · Last updated May 01, 2026 · Updated 20 times

Summary

This study tests two different radiation schedules for postmenopausal women with early-stage breast cancer. One group gets 5 daily doses, the other gets 3 doses every other day, both over one week. The goal is to see which schedule causes less breast scarring (fibrosis) while keeping cancer from coming back. 350 women will be followed for up to 10 years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT NEOPLASM OF BREAST STAGE I are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Brooklyn Methodist Hospital - NewYork Presbyterian

New York, New York, 11215, United States
New York Presbyterian Hospital - Queens

New York, New York, 11355, United States
University of Southern California

Los Angeles, California, 90033, United States
Weill Cornell Medical College

New York, New York, 10065, United States

Conditions

Explore the condition pages connected to this study.

MALIGNANT NEOPLASM OF BREAST STAGE I